Ho Chi Minh -based Cho Ray Hospital, one of Vietnam’s leading medical facilities, says it has successfully produced two new radioactive drugs used to diagnose, monitor, and treat prostate cancer and neuroendocrine tumors.
The two drugs are Ga-68 PSMA and Ga-68 Dotatate.
With the successful production of these two types of radioactive drugs, patients will no longer need to go abroad at high cost to access this treatment.
Dr. Nguyễn Xuân Cảnh, Head of the hospital’s Nuclear Medicine Department, said that Galium-68 PSMA (Ga-68 PSMA) in prostate cancer and Galium-68 Dotatate (Ga-68 Dotatate) in neuroendocrine tumors are used widely for patients in advanced countries around the world.
These two drugs were approved by the US Food and Drug Administration (FDA) in 2016 and 2020.
Read the news HERE.
Add Comment